Publications found:
55,654
Sort by:
Influenzavirus B Infections R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF INFLUENZAVIRUS B INFECTIONS PIPELINE REPORT INCLUDES Panorama of Influenzavirus B Infections pipeline markets including statistics on therapeutic drugs and companies involved Influenzavirus B Infections Pipeline candidates across various development ...
August 2018
100 pages
Insomnia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF INSOMNIA PIPELINE REPORT INCLUDES Panorama of Insomnia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
90 pages
Insulin Resistance R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF INSULIN RESISTANCE PIPELINE REPORT INCLUDES Panorama of Insulin Resistance pipeline markets including statistics on therapeutic drugs and companies involved Insulin Resistance Pipeline candidates across various development ...
August 2018
40 pages
Intermittent Claudication R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF INTERMITTENT CLAUDICATION PIPELINE REPORT INCLUDES Panorama of Intermittent Claudication pipeline markets including statistics on therapeutic drugs and companies involved Intermittent Claudication Pipeline candidates across various development ...
August 2018
40 pages
Interstitial Cystitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF INTERSTITIAL CYSTITIS PIPELINE REPORT INCLUDES Panorama of Interstitial Cystitis pipeline markets including statistics on therapeutic drugs and companies involved Interstitial Cystitis Pipeline candidates across various development ...
August 2018
70 pages
Iron Deficiency Anemia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF IRON DEFICIENCY ANEMIA PIPELINE REPORT INCLUDES Panorama of Iron Deficiency Anemia pipeline markets including statistics on therapeutic drugs and companies involved Iron Deficiency Anemia Pipeline candidates across various development ...
August 2018
60 pages
Irritable Bowel Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF IRRITABLE BOWEL SYNDROME PIPELINE REPORT INCLUDES Panorama of Irritable Bowel Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Irritable Bowel Syndrome Pipeline candidates across various development ...
August 2018
120 pages
Ischemia Reperfusion Injury R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ISCHEMIA REPERFUSION INJURY PIPELINE REPORT INCLUDES Panorama of Ischemia Reperfusion Injury pipeline markets including statistics on therapeutic drugs and companies involved Ischemia Reperfusion Injury Pipeline candidates across various development ...
August 2018
130 pages
Japanese Encephalitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF JAPANESE ENCEPHALITIS PIPELINE REPORT INCLUDES Panorama of Japanese Encephalitis pipeline markets including statistics on therapeutic drugs and companies involved Japanese Encephalitis Pipeline candidates across various development ...
August 2018
40 pages
Juvenile Macular Degeneration (Stargardt Disease) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... use format. SCOPE OF JUVENILE MACULAR DEGENERATION (STARGARDT DISEASE) PIPELINE REPORT INCLUDES Panorama of Juvenile Macular Degeneration (Stargardt Disease) pipeline markets including statistics on therapeutic drugs and companies involved Juvenile Macular Degeneration (Stargardt Disease) Pipeline candidates ...
August 2018
60 pages
Kaposi Sarcoma R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF KAPOSI SARCOMA PIPELINE REPORT INCLUDES Panorama of Kaposi Sarcoma pipeline markets including statistics on therapeutic drugs and companies involved Kaposi Sarcoma Pipeline candidates across various development ...
August 2018
180 pages
Keloids R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF KELOIDS PIPELINE REPORT INCLUDES Panorama of Keloids pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Kennedy’s Disease R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF KENNEDY’S DISEASE PIPELINE REPORT INCLUDES Panorama of Kennedy’s Disease pipeline markets including statistics on therapeutic drugs and companies involved Kennedy’s Disease Pipeline candidates across various development ...
August 2018
20 pages
Keratitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF KERATITIS PIPELINE REPORT INCLUDES Panorama of Keratitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
50 pages
Kidney Fibrosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF KIDNEY FIBROSIS PIPELINE REPORT INCLUDES Panorama of Kidney Fibrosis pipeline markets including statistics on therapeutic drugs and companies involved Kidney Fibrosis Pipeline candidates across various development ...
August 2018
110 pages
Kidney Transplant Rejection R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF KIDNEY TRANSPLANT REJECTION PIPELINE REPORT INCLUDES Panorama of Kidney Transplant Rejection pipeline markets including statistics on therapeutic drugs and companies involved Kidney Transplant Rejection Pipeline candidates across various development ...
August 2018
130 pages
Klebsiella pneumoniae Infections R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE REPORT INCLUDES Panorama of Klebsiella pneumoniae Infections pipeline markets including statistics on therapeutic drugs and companies involved Klebsiella pneumoniae Infections Pipeline candidates across various development ...
August 2018
90 pages
Lassa Fever (Lassa Hemorrhagic Fever) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF LASSA FEVER (LASSA HEMORRHAGIC FEVER) PIPELINE REPORT INCLUDES Panorama of Lassa Fever (Lassa Hemorrhagic Fever) pipeline markets including statistics on therapeutic drugs and companies involved Lassa Fever (Lassa Hemorrhagic Fever) Pipeline candidates across ...
August 2018
40 pages
Leber Congenital Amaurosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF LEBER CONGENITAL AMAUROSIS PIPELINE REPORT INCLUDES Panorama of Leber Congenital Amaurosis pipeline markets including statistics on therapeutic drugs and companies involved Leber Congenital Amaurosis Pipeline candidates across various development ...
August 2018
50 pages
Leber’s Hereditary Optic Neuropathy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF LEBER’S HEREDITARY OPTIC NEUROPATHY PIPELINE REPORT INCLUDES Panorama of Leber’s Hereditary Optic Neuropathy pipeline markets including statistics on therapeutic drugs and companies involved Leber’s Hereditary Optic Neuropathy Pipeline candidates across ...
August 2018
50 pages
Left Ventricular Dysfunction R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF LEFT VENTRICULAR DYSFUNCTION PIPELINE REPORT INCLUDES Panorama of Left Ventricular Dysfunction pipeline markets including statistics on therapeutic drugs and companies involved Left Ventricular Dysfunction Pipeline candidates across various development ...
August 2018
40 pages
Leiomyosarcoma R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF LEIOMYOSARCOMA PIPELINE REPORT INCLUDES Panorama of Leiomyosarcoma pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
200 pages
Leishmaniasis (Kala Azar) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF LEISHMANIASIS (KALA AZAR) PIPELINE REPORT INCLUDES Panorama of Leishmaniasis (Kala Azar) pipeline markets including statistics on therapeutic drugs and companies involved Leishmaniasis (Kala Azar) Pipeline candidates across various development ...
August 2018
100 pages
Lennox Gastaut Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF LENNOX GASTAUT SYNDROME PIPELINE REPORT INCLUDES Panorama of Lennox Gastaut Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Lennox Gastaut Syndrome Pipeline candidates across various development ...
August 2018
50 pages
Lewy body Dementia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF LEWY BODY DEMENTIA PIPELINE REPORT INCLUDES Panorama of Lewy body Dementia pipeline markets including statistics on therapeutic drugs and companies involved Lewy body Dementia Pipeline candidates across various development ...
August 2018
40 pages
Lipodystrophy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF LIPODYSTROPHY PIPELINE REPORT INCLUDES Panorama of Lipodystrophy pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Liposarcoma R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF LIPOSARCOMA PIPELINE REPORT INCLUDES Panorama of Liposarcoma pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
130 pages
Liver Cirrhosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF LIVER CIRRHOSIS PIPELINE REPORT INCLUDES Panorama of Liver Cirrhosis pipeline markets including statistics on therapeutic drugs and companies involved Liver Cirrhosis Pipeline candidates across various development ...
August 2018
70 pages
Liver Transplant Rejection R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF LIVER TRANSPLANT REJECTION PIPELINE REPORT INCLUDES Panorama of Liver Transplant Rejection pipeline markets including statistics on therapeutic drugs and companies involved Liver Transplant Rejection Pipeline candidates across various development ...
August 2018
60 pages
Low Back Pain R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF LOW BACK PAIN PIPELINE REPORT INCLUDES Panorama of Low Back Pain pipeline markets including statistics on therapeutic drugs and companies involved Low Back Pain Pipeline candidates across various development ...
August 2018
80 pages
Lung Transplant Rejection R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF LUNG TRANSPLANT REJECTION PIPELINE REPORT INCLUDES Panorama of Lung Transplant Rejection pipeline markets including statistics on therapeutic drugs and companies involved Lung Transplant Rejection Pipeline candidates across various development ...
August 2018
50 pages
Lupus Nephritis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF LUPUS NEPHRITIS PIPELINE REPORT INCLUDES Panorama of Lupus Nephritis pipeline markets including statistics on therapeutic drugs and companies involved Lupus Nephritis Pipeline candidates across various development ...
August 2018
110 pages
Lyme Disease R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF LYME DISEASE PIPELINE REPORT INCLUDES Panorama of Lyme Disease pipeline markets including statistics on therapeutic drugs and companies involved Lyme Disease Pipeline candidates across various development ...
August 2018
30 pages
Lymphatic Filariasis (Elephantiasis) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF LYMPHATIC FILARIASIS (ELEPHANTIASIS) PIPELINE REPORT INCLUDES Panorama of Lymphatic Filariasis (Elephantiasis) pipeline markets including statistics on therapeutic drugs and companies involved Lymphatic Filariasis (Elephantiasis) Pipeline candidates across various development ...
August 2018
20 pages
Macular Edema R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF MACULAR EDEMA PIPELINE REPORT INCLUDES Panorama of Macular Edema pipeline markets including statistics on therapeutic drugs and companies involved Macular Edema Pipeline candidates across various development ...
August 2018
40 pages
Major Depressive Disorder R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF MAJOR DEPRESSIVE DISORDER PIPELINE REPORT INCLUDES Panorama of Major Depressive Disorder pipeline markets including statistics on therapeutic drugs and companies involved Major Depressive Disorder Pipeline candidates across various development ...
August 2018
160 pages
Male Hypogonadism R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF MALE HYPOGONADISM PIPELINE REPORT INCLUDES Panorama of Male Hypogonadism pipeline markets including statistics on therapeutic drugs and companies involved Male Hypogonadism Pipeline candidates across various development ...
August 2018
80 pages
Male Infertility R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF MALE INFERTILITY PIPELINE REPORT INCLUDES Panorama of Male Infertility pipeline markets including statistics on therapeutic drugs and companies involved Male Infertility Pipeline candidates across various development ...
August 2018
30 pages
Malignant Pleural Effusion R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF MALIGNANT PLEURAL EFFUSION PIPELINE REPORT INCLUDES Panorama of Malignant Pleural Effusion pipeline markets including statistics on therapeutic drugs and companies involved Malignant Pleural Effusion Pipeline candidates across various development ...
August 2018
30 pages
Marburg Hemorrhagic Fever R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF MARBURG HEMORRHAGIC FEVER PIPELINE REPORT INCLUDES Panorama of Marburg Hemorrhagic Fever pipeline markets including statistics on therapeutic drugs and companies involved Marburg Hemorrhagic Fever Pipeline candidates across various development ...
August 2018
60 pages
Measles R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF MEASLES PIPELINE REPORT INCLUDES Panorama of Measles pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Medullary Thyroid Cancer R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF MEDULLARY THYROID CANCER PIPELINE REPORT INCLUDES Panorama of Medullary Thyroid Cancer pipeline markets including statistics on therapeutic drugs and companies involved Medullary Thyroid Cancer Pipeline candidates across various development ...
August 2018
80 pages
Medulloblastoma R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF MEDULLOBLASTOMA PIPELINE REPORT INCLUDES Panorama of Medulloblastoma pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
160 pages
Melasma (Chlosma) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF MELASMA (CHLOSMA) PIPELINE REPORT INCLUDES Panorama of Melasma (Chlosma) pipeline markets including statistics on therapeutic drugs and companies involved Melasma (Chlosma) Pipeline candidates across various development ...
August 2018
20 pages
Melioidosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF MELIOIDOSIS PIPELINE REPORT INCLUDES Panorama of Melioidosis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
50 pages
Meniere Disease R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF MENIERE DISEASE PIPELINE REPORT INCLUDES Panorama of Meniere Disease pipeline markets including statistics on therapeutic drugs and companies involved Meniere Disease Pipeline candidates across various development ...
August 2018
40 pages
Meningioma R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF MENINGIOMA PIPELINE REPORT INCLUDES Panorama of Meningioma pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
200 pages
Meningitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF MENINGITIS PIPELINE REPORT INCLUDES Panorama of Meningitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Metachromatic Leukodystrophy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF METACHROMATIC LEUKODYSTROPHY PIPELINE REPORT INCLUDES Panorama of Metachromatic Leukodystrophy pipeline markets including statistics on therapeutic drugs and companies involved Metachromatic Leukodystrophy Pipeline candidates across various development ...
August 2018
30 pages
Metastatic Hepatocellular Carcinoma R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF METASTATIC HEPATOCELLULAR CARCINOMA PIPELINE REPORT INCLUDES Panorama of Metastatic Hepatocellular Carcinoma pipeline markets including statistics on therapeutic drugs and companies involved Metastatic Hepatocellular Carcinoma Pipeline candidates across various development ...
August 2018
100 pages
